Evidence map›Paper›PMID 42649807›Full record

ReviewBioengineering (Basel, Switzerland)2026

Aerosol Jet Printing in Biotechnologies.

Pasquale D'Angelo, Giuseppe Tarabella

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pasquale D'AngeloInstitute of Materials for Electronics and Magnetism, Parco Area delle Scienze 37/A, 43124 Parma, Italy.ORCID 0000-0002-4500-4457
Giuseppe TarabellaInstitute of Materials for Electronics and Magnetism, Parco Area delle Scienze 37/A, 43124 Parma, Italy.ORCID 0000-0002-8898-714X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aerosol jet printing, AJP, has emerged as a versatile direct ink writing technology enabling high-resolution, non-contact patterning of diverse biomaterials across a broad viscosity range. This capability facilitates the fabrication of complex micro- and mesoscale architectures on planar and non-planar substrates, advancing applications in biosensing, microfluidics, tissue engineering, and drug delivery fields. Herein, we review the integration of this high-resolution, rapid prototyping method with bioinks, including proteins, DNA, collagen, gelatin, and silk fibroin, and analyze how processing parameters influence structural and functional outcomes designed for applications for the above mentioned biotechnological fields. The ability by aerosol jet printing to combine structural, electrical, and biological functionalities within single platforms supports the development of multifunctional biomedical devices with higher potential than those produced using other direct ink writing techniques. While challenges such as bioink stability and process scalability, as well as the lack of deeper analyses about the efficiency of real applications of aerosol-jet-printed biotools, still remain open, AJP demonstrates significant promise as an enabling technology for next-generation biofabrication, offering new avenues for personalized and flexible biomedical applications.

Indexed as

aerosol jet printingbioinksbiotechnologydrug deliverytissue engineering

Identifiers

PMID42649807
PMCPMC13510192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.